← Back to Search

Behavioural Intervention

Active aging with resilience (AR) for Healthy Aging (AAT Trial)

N/A

Recruiting

Led By Lixia Yang, PhD

Research Sponsored by Toronto Metropolitan University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up (1) pre-test (2) through study completion, an average of 1 month (3) 1-month post study completion

Awards & highlights

AAT Trial Summary

This trial aims to create a digital program to help older adults in Canada improve their physical, psychological, and social functions. The study involves two groups: Chinese older immigrants and English-speaking White Canadian older adults

Who is the study for?

This trial is for older adults aged 60 and above, including Chinese immigrants in Canada and English-speaking White Canadian seniors. It's designed to help with healthy aging, stress relief, cognitive function improvement, reducing loneliness, and enhancing social interactions.Check my eligibility

What is being tested?

The study tests a digital active aging program with resilience training versus traditional active aging training or workshop series on topics related to aging. Participants will undergo pretest-training-posttest sessions over Zoom for four weeks.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like workshops and exercises, side effects are minimal but may include discomfort from new physical activities or potential stress from cognitive tasks.

AAT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ (1) pre-test (2) through study completion, an average of 1 month (3) 1-month post study completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~(1) pre-test (2) through study completion, an average of 1 month (3) 1-month post study completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and (1) pre-test (2) through study completion, an average of 1 month (3) 1-month post study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Conner-Davidson Resilience Scale 10-item (CD RISC-10)

Divided attention test

Emotional regulation Questionnaire (ERQ)

+9 more

Secondary outcome measures

Instrumental Activities of Daily Living(IADL)

Satisfaction with life scale (SWLS)

The 6-item De Jong Gierveld Loneliness Scale

+1 more

AAT Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Active aging with resilience (AR)Experimental Treatment4 Interventions

In the "active aging with resilience (AR)" condition, participants will complete physical, cognitive, and social engagement training modules, starting with a 15-min resilience-building module.

Group II: Active aging without resilience (AA)Active Control3 Interventions

The traditional "active aging" (AA) training involves the same multi-domain active aging training without the initial resilience-building module, which will be replaced by watching 15 minutes of educational video on topics such as health, nature or travel.

Group III: Workshop training (WT)Placebo Group1 Intervention

The "workshop training" (WT) control condition involves workshops following the same 4-week schedule on aging-related topics.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

physical exercise

2008

Completed Phase 4

~750

cognitive training

2020

N/A

~420

social interaction

2017

N/A

~50

Resilience training

2020

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CognicitiUNKNOWN

CognifitUNKNOWN

AGE-WELL and the Canadian Frailty NetworkUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"As per clinicaltrials.gov, this particular research endeavor is no longer in the recruitment phase. The trial was initially posted on March 1st, 2024, and had its final edit on February 13th, 2024. Despite this study being closed for enrollment, there are currently 224 other trials actively seeking participants."

Answered by AI

What is the primary objective of this medical study?

"This clinical trial aims to assess Exercise Self-efficacy level (ESES) from baseline through study completion, with follow-up at 1 month post-study. Secondary outcomes include Satisfaction with Life Scale (SWLS), Instrumental Activities of Daily Living (IADL), and The Brief Approach/Avoidance Coping Questionnaire (BACQ). Higher scores on SWLS signify greater life satisfaction perception, while higher IADL scores reflect improved daily activity performance. BACQ approach and avoidance scores indicate problem-solving tendencies regarding health issues."

Answered by AI

Recent research and studies

International Journal of Behavioral MedicineJournal

The Brief Resilience Scale: Assessing the Ability to Bounce Back

Smith, Bruce W., Jeanne Dalen, Kathryn Wiggins, Erin Tooley, Paulette Christopher, and Jennifer Bernard. 2008. “The Brief Resilience Scale: Assessing the Ability to Bounce Back”. International Journal of Behavioral Medicine. Springer Science and Business Media LLC. doi:10.1080/10705500802222972.

clinicaltrials.govStudy

A Digital Active Aging Training Program for Older Adults

Lixia Yang 2024. "A Digital Active Aging Training Program for Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06270862.